<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
>

<channel rdf:about="http://www.buffalo.edu/news/list-page.html?key=d-bioinformatics">
<title>UB Bioniformatics News</title>
<link>http://www.buffalo.edu/news/list-page.html?key=d-bioinformatics</link>
<description></description>
<dc:language>en-US</dc:language>
<dc:rights>Copyright 2008, University at Buffalo</dc:rights>
<dc:date>2008-05-17T10:20:53-04:00</dc:date>
<dc:publisher>apage@buffalo.edu</dc:publisher>
<dc:creator>apage@buffalo.edu</dc:creator>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.buffalo.edu/news/9368" />
  <rdf:li rdf:resource="http://www.buffalo.edu/news/8821" />
  <rdf:li rdf:resource="http://www.buffalo.edu/news/8712" />
  <rdf:li rdf:resource="http://www.buffalo.edu/news/8681" />
  <rdf:li rdf:resource="http://www.buffalo.edu/news/8504" />
  <rdf:li rdf:resource="http://www.buffalo.edu/news/8447" />
  <rdf:li rdf:resource="http://www.buffalo.edu/news/8366" />
  <rdf:li rdf:resource="http://www.buffalo.edu/news/8265" />
  <rdf:li rdf:resource="http://www.buffalo.edu/news/8101" />
  <rdf:li rdf:resource="http://www.buffalo.edu/news/8051" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://www.buffalo.edu/news/9368">
<title>County Executive Chris Collins to Kick Off &apos;Pre-Seed&apos; Workshop</title>
<link>http://www.buffalo.edu/news/9368</link>
<description>Erie County Executive Chris Collins will make opening remarks at a dinner to kick off a &apos;pre-seed&apos; workshop for Western New York researchers and entrepreneurs considering the launch of a technology-based business.</description>
<dc:date>2008-05-06T00:00:00-04:00</dc:date>
<dc:identifier>93680009</dc:identifier>
</item>

<item rdf:about="http://www.buffalo.edu/news/8821">
<title>Nanotechnology Identifies Peptide &quot;Fingerprint&quot; in Both Forms of ALS</title>
<link>http://www.buffalo.edu/news/8821</link>
<description>A nanotechnology developed by a University at Buffalo professor has enabled researchers to identify a molecular signature common to both familial and sporadic cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig&apos;s disease.</description>
<dc:date>2007-09-04T00:00:00-04:00</dc:date>
<dc:identifier>88210009</dc:identifier>
</item>

<item rdf:about="http://www.buffalo.edu/news/8712">
<title>Workshop in Computational Science Challenges High School Students</title>
<link>http://www.buffalo.edu/news/8712</link>
<description>A dozen lucky high school students are spending two weeks this summer at the University at Buffalo&apos;s Center for Computational Research, part of the university&apos;s New York State Center of Excellence in Bioinformatics and Life Sciences, during its annual high school workshop in computational science, from June 25 to July 6.</description>
<dc:date>2007-06-26T00:00:00-04:00</dc:date>
<dc:identifier>87120009</dc:identifier>
</item>

<item rdf:about="http://www.buffalo.edu/news/8681">
<title>UB CAT Supports Researchers&apos; Collaboration with Industry</title>
<link>http://www.buffalo.edu/news/8681</link>
<description>The UB Center for Advanced Biomedical and Bioengineering Technology (UB CAT) is funding University at Buffalo researchers working with 13 life sciences companies and organizations in Buffalo Niagara as part of $1 million in annual support provided by the New York State Foundation for Science, Technology and Innovation (NYSTAR) to the UB CAT.</description>
<dc:date>2007-06-14T00:00:00-04:00</dc:date>
<dc:identifier>86810009</dc:identifier>
</item>

<item rdf:about="http://www.buffalo.edu/news/8504">
<title>North Carolina Company to Relocate to UB&apos;s Center Of Excellence</title>
<link>http://www.buffalo.edu/news/8504</link>
<description>Medcotek, Inc., a North Carolina medical-technology company, is relocating to the New York State Center of Excellence in Bioinformatics and Life Sciences as the result of a strategic partnership between local companies Buffalo BioSciences and E-Capital Financing.</description>
<dc:date>2007-03-15T00:00:00-04:00</dc:date>
<dc:identifier>85040009</dc:identifier>
</item>

<item rdf:about="http://www.buffalo.edu/news/8447">
<title>CCR Increases Computing Power, Interactions with Researchers</title>
<link>http://www.buffalo.edu/news/8447</link>
<description>Over the past year, the University at Buffalo&apos;s Center for Computational Research has quadrupled computing power, upgraded its high-performance storage system and installed a new state-of-the-art visualization room. If that wasn&apos;t enough, it also moved its entire infrastructure, including a 2,000-processor supercomputer, from the university&apos;s North Campus into UB&apos;s New York State Center of Excellence in Bioinformatics and Life Sciences on the Buffalo Niagara Medical Campus in downtown Buffalo.</description>
<dc:date>2007-02-22T00:00:00-04:00</dc:date>
<dc:identifier>84470009</dc:identifier>
</item>

<item rdf:about="http://www.buffalo.edu/news/8366">
<title>Toronto Company Locates In Buffalo Niagara to Partner with Region&apos;s Biotech Industry</title>
<link>http://www.buffalo.edu/news/8366</link>
<description>In what can be described as a &quot;win&quot; for Buffalo Niagara&apos;s emerging biotechnology industry, an international pharmaceutical consulting company has relocated an office to the region to establish partnerships with the University at Buffalo and benefit from the region&apos;s biotech assets.</description>
<dc:date>2007-01-22T00:00:00-04:00</dc:date>
<dc:identifier>83660009</dc:identifier>
</item>

<item rdf:about="http://www.buffalo.edu/news/8265">
<title>New Pathway Revealed for Drugs Treating Cognitive, Mental Disorders</title>
<link>http://www.buffalo.edu/news/8265</link>
<description>In their continuing search for promising targets for treating mental disorders, a group of neuroscientists at the University at Buffalo has identified a pathway critical to the functioning of antidepressants, antipsychotic drugs and drugs for anxiety disorders.</description>
<dc:date>2006-11-17T00:00:00-04:00</dc:date>
<dc:identifier>82650009</dc:identifier>
</item>

<item rdf:about="http://www.buffalo.edu/news/8101">
<title>Study Focuses on Brain Receptor Involved in Cognitive Disorders</title>
<link>http://www.buffalo.edu/news/8101</link>
<description>Only one drug is approved to treat persons with mild to moderate Alzheimer&apos;s symptoms, despite the fact that the brain protein at the core of this disease, the NMDA receptor, is known to play a central role in several acute and chronic neurodegenerative conditions that impair learning and memory. Gabriela Popescu, Ph.D., assistant professor of biochemistry at the University at Buffalo&apos;s School of Medicine and Biomedical Sciences, is hoping to help change that situation.</description>
<dc:date>2006-08-02T00:00:00-04:00</dc:date>
<dc:identifier>81010009</dc:identifier>
</item>

<item rdf:about="http://www.buffalo.edu/news/8051">
<title>&lt;b&gt;New York Times:&lt;/b&gt; UB&apos;s Center of Excellence in Bioinformatics and Life Sciences spurs Buffalo biotech industry</title>
<link>http://www.buffalo.edu/news/8051</link>
<description>An article in the Sunday edition of the &lt;i&gt;New York Times&lt;/i&gt; describes how UB&apos;s New York State Center of Excellence in Bioinformatics and Life Sciences is helping to create a new biotech industry in Buffalo.</description>
<dc:date>2006-07-12T00:00:00-04:00</dc:date>
<dc:identifier>80510009</dc:identifier>
</item>

</rdf:RDF>